Pérez-Fernández Xosé, Sabater-Riera Joan, Ballus-Noguera Josep, Cárdenas-Campos Paola, Moreno-González Gabriel, Alonso-Juste Virginia, Corral-Velez Vicente, Gutierrez-Arámbula Diana, Gumucio-Sanguino Victor, Betbesé-Roig Antoni, Liu Kathleen D
Clin Nephrol. 2017 Aug;88(8):105-111. doi: 10.5414/CN109134.
The impact of Surviving Sepsis Campaign (SSC) care bundles in reducing sepsis-associated acute kidney injury (SA-AKI) was evaluated.
We conducted an observational single-center cohort study. Accomplishment of SSC care bundles was registered in all patients with severe sepsis admitted to the critical care department of a university hospital during three different periods. The main outcome measured was SA-AKI incidence defined as any worsening of AKI stage within the first 7 days from onset of sepsis.
Among 260 patients with severe sepsis or septic shock finally meeting inclusion criteria, 82 (31.5%) patients developed SA-AKI. None of the SSC care tasks significantly decreased SA-AKI incidence, although a trend was observed with an initial better blood glucose control as well as with a more protective ventilation strategy. Hypotension requiring fluid challenge (hazard ratio (HR), 2.3; 95% confidence interval (CI), 1.2 - 4.2) and the presence of an abdominal sepsis etiology (HR, 1.8; 95% CI, 1.1 - 3.1) were independently associated with SA-AKI. Patients who developed SA-AKI had a higher 90-day mortality rate (62.2 vs. 40.4%).
CONCLUSION: In a cohort of septic patients, none of the SSC care tasks significantly decreased SA-AKI incidence within the first week after onset of sepsis. .
评估了拯救脓毒症运动(SSC)护理集束在降低脓毒症相关急性肾损伤(SA-AKI)方面的影响。
我们进行了一项单中心观察性队列研究。在三个不同时期,对入住大学医院重症监护科的所有严重脓毒症患者的SSC护理集束完成情况进行了记录。主要测量的结局是SA-AKI发病率,定义为脓毒症发作后前7天内急性肾损伤(AKI)分期的任何恶化。
在最终符合纳入标准的260例严重脓毒症或脓毒性休克患者中,82例(31.5%)发生了SA-AKI。尽管观察到血糖初始控制较好以及采用更具保护性的通气策略有降低SA-AKI发病率的趋势,但没有一项SSC护理任务能显著降低SA-AKI发病率。需要液体冲击的低血压(风险比(HR),2.3;95%置信区间(CI),1.2 - 4.2)和腹部脓毒症病因的存在(HR,1.8;95%CI,1.1 - 3.1)与SA-AKI独立相关。发生SA-AKI的患者90天死亡率更高(62.2%对40.4%)。
在脓毒症患者队列中,在脓毒症发作后的第一周内,没有一项SSC护理任务能显著降低SA-AKI发病率。